Concepedia

Author

Jerzy Z. Błoński

Medical University of Lodz

Also Known As

J Błoński, J Z Blonski, J Z Bloński, J Z Błonski, J Z Błoński, J. Blonski, J. Z. Blonski, J. Z. Błoński, J.Z Błoński, J.Z. Blonski

109

Publications

1.6K

Citations

23

H-Index

58

Concepts

All Affiliations

Medical University of LodzCopernicus Memorial HospitalInstytut Hematologii i TransfuzjologiUniversity of ŁódźMedical University of Lublin
JZ

About

Jerzy Z. Błoński is an author at Medical University of Lodz specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

441

2

Health Sciences

4

4

160

3

Cell Biology

2

2

43

4

Engineering

1

1

17

5

Clinical Immunology

1

1

54

Jerzy Z. Błoński

×

28

Publications

849

Citations

19

H-Index

YearCitations

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor,

Journal of Clinical Oncology

2010

99

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor,

Blood

2007

75

Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial

Tadeusz Robak, Krzysztof Warzocha, Govind Babu,

Leukemia & lymphoma/Leukemia and lymphoma

2016

57

Lymphocytes Tγδ in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity

Ewa Robak, H Niewiadomska, Tadeusz Robak,

Mediators of Inflammation

2001

54

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut,

Cancer

2006

50

Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut,

European Journal Of Haematology

2007

48

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia

Tadeusz Robak, Jerzy Z. Błoński, Marek Kasznicki,

The Hematology Journal

2002

43

Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre‐treated patients with advanced indolent lymphoid malignancies

Tadeusz Robak, Joanna Góra‐Tybor, Ewa Lech‐Marańda,

European Journal Of Haematology

2001

32

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.

Joanna Góra‐Tybor, Jerzy Z. Błoński, Tadeusz Robak

PubMed

2005

30

Rituximab Followed by Cladribine in the Treatment of Heavily Pretreated Patients with Indolent Lymphoid Malignancies

Tadeusz Robak, Piotr Smolewski, H Urbańska-Ryś,

Leukemia & lymphoma/Leukemia and lymphoma

2004

29

Page 1